医院手术量对机器人辅助部分肾切除术结局的影响
基于美国国家癌症数据库2010—2013年18 724例接受机器人辅助部分肾切除术的肾细胞癌患者,按医院年手术量五分位分组分析。结果显示手术量较高与转开放、延长住院和切缘阳性的 odds 降低相关,但30天和90天死亡率无显著差异。
要点
- 高手术量医院与更低的转开放、延长住院和切缘阳性 odds 相关
- 30天和90天死亡率在五个手术量组间无显著差异
- 30天再入院率仅在未校正分析中有差异,校正后无差异
核心结论
- 在高手术量医院接受机器人辅助部分肾切除术可能获得更好的围手术期结局(转开放和住院时间)及更低的切缘阳性率。
- 未来需要研究探索高手术量医院结局更优的具体组成部分。
研究设计与样本
- 回顾性队列研究,利用美国国家癌症数据库识别2010—2013年接受机器人辅助部分肾切除术的肾细胞癌患者。
- 共纳入18 724例,按医院年手术量五分位分组:极低量1-7例(n=3 693)、低量8-14例(n=3 719)、中量15-23例(n=3 833)、高量24-43例(n=3 649)、极高量≥44例(n=3 830)。
- 采用未校正分析和多因素logistic回归比较结局,并以医院手术量为连续变量进行敏感性分析。
主要发现
- 30天死亡率和90天死亡率在五个手术量组间无显著差异。
- 以极低量为参照,中量(OR 0.60,P=0.001)、高量(OR 0.57,P<0.001)和极高量(OR 0.47,P<0.001)的转开放 odds 更低;低量 OR 0.88,P=0.377。
- 以极低量为参照,中量(OR 0.75,P<0.001)、高量(OR 0.62,P<0.001)和极高量(OR 0.45,P<0.001)的延长住院 odds 更低;低量 OR 0.93,P=0.197。
- 以极低量为参照,低量(OR 0.76,P<0.001)、中量(OR 0.76,P<0.001)、高量(OR 0.59,P<0.001)和极高量(OR 0.34,P<0.001)的切缘阳性 odds 更低。
- 敏感性分析显示医院手术量每增加1例,转开放(OR 0.986,P<0.001)、延长住院(OR 0.989,P<0.001)和切缘阳性(OR 0.984,P<0.001)的 odds 更低;30天再入院率仅在未校正分析中有差异,校正后无差异。
关键数值与推荐
- 延长住院定义为住院时间>3天。
- 医院年手术量五分位分组:极低量1-7例、低量8-14例、中量15-23例、高量24-43例、极高量≥44例。
临床怎么用
- 接受机器人辅助部分肾切除术的肾细胞癌患者,在高手术量医院手术可能与更低的转开放、延长住院和切缘阳性 odds 相关。
- 30天和90天死亡率在不同手术量医院间无显著差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of hospital volume on outcomes of robot-assisted partial nephrectomy (RAPN). MATERIALS AND METHODS: Patients with renal cell carcinoma who underwent RAPN between 2010 and 2013 were identified in the National Cancer Database. Hospital yearly RAPN volume was categorized into groups by sorting patients as closely as possible into five groups of equal size (quintiles): very low; low; medium; high; and very high volume. Outcomes included 30-day mortality, 90-day mortality, open conversion, prolonged length of hospital stay (PLOS; defined as >3 days), 30-day readmission rate, and positive surgical margin (PSM) rate. Unadjusted analyses and multivariable logistic regressions were used to compare outcomes. Sensitivity analyses with hospital volume considered as a continuous variable were also performed. RESULTS: A total of 18 724 RAPN cases were included. Hospital volume quintiles were: very low volume, 1-7 cases (n = 3 693); low volume, 8-14 cases (n = 3 719); medium volume, 15-23 cases (n = 3 833); high volume, 24-43 cases (n = 3 649); and very high volume, ≥44 cases (n = 3 830). There was no significant difference in 30-day or 90-day mortality among the five groups. Multivariable logistic regression analysis (reference: very low volume) showed that higher hospital volume was associated with lower odds of conversion (low [odds ratio {OR}: 0.88; P = 0.377]; medium [OR: 0.60; P = 0.001]; high [OR: 0.57; P < 0.001]; very high [OR: 0.47; P < 0.001]), lower odds of PLOS (low [OR: 0.93; P = 0.197], medium [OR: 0.75; P < 0.001]; high [OR: 0.62; P < 0.001]; very high [OR: 0.45; P < 0.001]), and lower odds of PSMs (low [OR: 0.76; P < 0.001]; medium [OR: 0.76, P < 0.001]; high [OR: 0.59; P < 0.001]; very high [OR: 0.34; P < 0.001]). Sensitivity analyses confirmed increasing hospital volume (per 1-case increase) was associated with lower odds of conversion (OR: 0.986; P < 0.001), PLOS (OR: 0.989; P < 0.001) and PSMs (OR: 0.984; P < 0.001). A difference in 30-day readmission rate was found in unadjusted analysis but not in adjusted analyses. CONCLUSION: Undergoing RAPN at higher-volume hospitals may have better peri-operative outcomes (conversion to open and LOS) and lower PSM rates. Future studies are needed to explore the detailed components that lead to the superior outcomes in higher-volume hospitals.
引用
- Xia L, Pulido JE, Chelluri RR, et al. Hospital volume and outcomes of robot-assisted partial nephrectomy. BJU Int. 2018. PMID: 29232025. doi:10.1111/bju.14099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。